» Articles » PMID: 30341386

Association of Cervical Microbial Community with Persistence, Clearance and Negativity of Human Papillomavirus in Korean Women: a Longitudinal Study

Overview
Journal Sci Rep
Specialty Science
Date 2018 Oct 21
PMID 30341386
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to identify the cervical microbes that are associated with HPV negativity, HPV clearance and HPV persistence and to assess the microbes' longitudinal associations as related to HPV infection dynamics among Korean women. We enrolled 41 women with 107 samples, and classified them according to the HPV infection dynamics: HPV negativity (21 samples, 10 subjects), HPV clearance (42 samples, 15 subjects), and HPV persistence (44 samples, 16 subjects). Cervical swabs were collected at the baseline and six-month-interval follow-up visits. HPV positivity was determined by HPV DNA HC2 assay, and the microbiome was analyzed using 16SrRNA pyrosequencing, linear discriminant analysis effect size and multivariate logistic analysis. In the multivariate logistic analysis results, Lactobacillus crispatus (multivariate OR (mOR) = 8.25, 95% CI 2.13~32.0) was predominant in the HPV-negative group. We observed that Eubacterium eligens (mOR = 11.5, 95% CI 1.31~101.4), Gardnerella vaginalis (mOR = 17.0, 95% CI 2.18-131.8), and Ureaplasma urealyticum (mOR = 7.42, 95% CI 1.3-42.46) had the strongest associations with HPV clearance, and Lactobacillus johnsonii (mOR = 16.4, 95% CI 1.77-152.2) with HPV persistence. Overall, greater diversity was observed in HPV-persistence than in HPV-negative women. Our findings suggest that the presence and prevalence of a specific cervical microbiome are factors involved in HPV dynamics.

Citing Articles

Human papillomavirus, vaginal microbiota and metagenomics: the interplay between development and progression of cervical cancer.

Leon-Gomez P, Romero V Front Microbiol. 2025; 15:1515258.

PMID: 39911706 PMC: 11794528. DOI: 10.3389/fmicb.2024.1515258.


A Narrative Review of the Putative Etiologic Role and Diagnostic Utility of the Cervicovaginal Microbiome in Human Papillomavirus-Associated Cervical Carcinogenesis.

Logel M, Tope P, El-Zein M, Gonzalez E, Franco E J Med Virol. 2024; 96(11):e70027.

PMID: 39520096 PMC: 11600484. DOI: 10.1002/jmv.70027.


Temporal composition of the cervicovaginal microbiome associates with hrHPV infection outcomes in a longitudinal study.

Molina M, Leenders W, Huynen M, Melchers W, Andralojc K BMC Infect Dis. 2024; 24(1):552.

PMID: 38831406 PMC: 11145797. DOI: 10.1186/s12879-024-09455-1.


Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model.

Spurgeon M, Townsend E, Blaine-Sauer S, McGregor S, Horswill M, den Boon J mBio. 2024; 15(6):e0093324.

PMID: 38742830 PMC: 11237646. DOI: 10.1128/mbio.00933-24.


Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.

Shen J, Sun H, Chu J, Gong X, Liu X Infect Agent Cancer. 2024; 19(1):13.

PMID: 38641803 PMC: 11027553. DOI: 10.1186/s13027-024-00573-8.


References
1.
Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett W . Metagenomic biomarker discovery and explanation. Genome Biol. 2011; 12(6):R60. PMC: 3218848. DOI: 10.1186/gb-2011-12-6-r60. View

2.
Dahlstrom L, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L . Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev. 2011; 20(12):2541-50. DOI: 10.1158/1055-9965.EPI-11-0761. View

3.
Goodman M, Shvetsov Y, McDuffie K, Wilkens L, Zhu X, Thompson P . Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res. 2008; 68(21):8813-24. PMC: 2727731. DOI: 10.1158/0008-5472.CAN-08-1380. View

4.
Adebamowo S, Ma B, Zella D, Famooto A, Ravel J, Adebamowo C . and in the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection. Front Public Health. 2017; 5:140. PMC: 5483445. DOI: 10.3389/fpubh.2017.00140. View

5.
Di Paola M, Sani C, Clemente A, Iossa A, Perissi E, Castronovo G . Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci Rep. 2017; 7(1):10200. PMC: 5579045. DOI: 10.1038/s41598-017-09842-6. View